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Summary: The Laser-nephelometric technique is characterized by its easy handling, accuracy, good reproducibility
and especially by the short time in which reliable results are available. A very good correlation was found between
the results obtained by the electroimmunoassay and those obtained by Laser-nephelometry. In both techniques <*2-
macroglobulin is the largest serum protein that can be determined in normal unconcentrated cerebrospinal fluid
(CSF). This is of diagnostic significance, since the serum/CSF ratios of both albumin and a2-macroglobulin are used
as a parameter for the blood-CSF barrier condition.
Schnelle Bestimmung von Proteinen im Serum und Liquor cerebrospinalis mit der Laser-Nephelometrie
Zusammenfassung: Die Laser-Nephelometrie zeichnet sich durch einfache Handhabung, Genauigkeit und gute Re-
produzierbarkeit aus. Der größte Vorteil im Vergleich zu konventionellen Methoden liegt in der Zeitersparnis. Die
Korrelation der Ergebnisse, die mit der Laser-Nephelometrie und der elektroimmunologischen Proteinbestimmung
gewonnen wurden, war sehr gut. Das größte Serumprotein, das mit beiden Techniken in.normalem unkonzentrierten
Liquor bestimmt werden kann, ist das a2-Makroglobulin. Dies ist von diagnostischer Bedeutung, da der Proteingra-
dient der Serum-Liquor-Quotienten von Albumin and a2-Makroglobulin als Parameter der Blut-Liquor-Schranken-
funktion dient.
Introduction
In recent years the quantitative determination of single
proteins in biological fluids has become a diagnostic tool
of great significance. Using these methods, even those
proteins previously considered to be extraneous in nor-
mal cerebrospinal fluid e. g. fibrinogen, IgM and j3-lipo«
protein (1), can be detected.
Although the electroimmunoassay (2) was found to be
suitable in routine work (3) the application of Laser-
nephelometry or Laser light scattering immunoassay —
both terms are used synonymously — is a further pro-
gress in laboratory diagnostics. This assay is based upon
the formation of complexes between a particular antigen
and its specific antibody, that can be measured by nephe-
lometry, The major advantage of this technique is the
time saved in comparison with other methods.
Material and Methods
In the serum and cerebrospinal fluid of 50 patients suffering from
a variety of neurological diseases and psychiatric disorders, the
determination of albumin, IgG, IgA and a2-rnacroglobulin by the
routine electroimmunoassay (2,3) were compared with the re*
suits obtained by Laser light scattering immunoassay. Since a good
correlation was found between both immunological techniques
(see page 632) in routine work, the electroimmunoassay was re-
placed by the Laser light scattering immunoassay. These four pro-
teins were determined in specimens from 500 patients (both in-
and out-patients) between June and December 1977 in our hos-
pital, using only Laser-nephelometry. All cerebrospinal fluid
samples were free of erythrocytes. The total protein content of
cerebrospinal fluid was determined according to Lowry et al. (4).
In 200 of these 500 patients showing an increased total protein
level of cerebrospinal fluid (above 600 mg/1), the IgM and ß-
lipoprotein were measured additionally by Laser light scattering
immunoassay in both serum and cerebrospinal fluid.
Those samples investigated by both techniques were handled as
described elsewhere for the electroimmunoassay (3).
All determinations of proteins were made with the Laser-Nephe-
Ipmeter (Behring Institut, D355 Marburg, F. R. G.) and special
plastic cuvettes (W. S. Sarstedt, Supplied by the Behring
Institut) were used. Laser nephelometric (LN)-tested antisera were
applied. With the exception of 0-lipoprotein, which was measured
with 0-lipoprotein reference serum, laser nephelometry reference
serum was used. Both antisera and reference sera were obtained
from the Behring Institut.
Prior to each assay the antiserum was centrifuged for 5 minutes
at 2000 g. The turbidity of 20 per cent antiserum, diluted with
normal saline did not exceed 0.3 Volt at the output of the ne-
phelometer. The patients* sera and cerebrospinal fluids as well
as the reference sera were diluted with normal saline to yield
postreactive turbidities, which corresponded to 0.2 to 8.0 Volt
at the output of the nephelometer.
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The following dilution series were used for the standard curves:
Albumin = 1:2000 to 1:20 000, IgG = 1:300 to 1:6000, IgA =
1:100 to 1:1000, ot^m^croglObulm and /Mipoprotein = 1:50 to
1:1000, IgM = 1:25 to 1:400.
The patients1 sera weie diluted as follows:
IgA, IgM, <*2-macroglobulm, /Mipoproteiri = 1:201, IgG = 1:1005,
Albumin = 1:4020.
Cerebrospinal fluid was centrifuged before investigation to re-
move any light scattering components. The dilution factors for
cerebrospinal fluid were chosen according to its total protein
content (tab. 1).
Tab. 1. Dilution factors of cerebrospinal fluid found empirically
for the standard assay according to the total protein con-


















































To 0.1 ml sample add
0.16 ml normal saline.
Read and note blank values, which should not exceed 0.3 Volt
at the output of the nephelometer. Defective cuvettes are repla^
ced. Add 0.04 ml antiserum. Mix gently, air bubbles must be
avoided. Cover the cuvettes to keep off dust particles. Incubate
for one hour at room temperature. Read results and subtract the
blank values of the samples. For final evaluation construct stand-







Fig. 1. Reference curves for the determination of IgM after one
hour (broken line) and after two hours (drawn line)
incubation time.
measured in volts at the output of the nephelometer, against the
concentration of the reference sera in mg/1 in a double logarithmic
scale.
If the sera are taken from a fasting patient the blank turbidity is
sufficiently low to omit clearing by Frigen as proposed by the
manufacturer (5).
The turbidity resulting from the formation of antigen^antibody
complexes should not exceed 8 Volt at the output of the nephe-
lometer. Above a critical antigen level, the antigen-antibody
complexes descend to the bottom of the cuvette, apparently due
to the formation of aggregates during the incubation time of
one hour. If the voltage increment is lower than 0.2 V at the
output of the nephelometer the incubation time is prolonged for
another hour. The threshold of detection for cerebrospinal fluid
proteins can be increased by prolongation of the incubation time
(fig. 1) or replacement of saline by cerebrospinal fluid.
The addition of polyethylene glycol (Mr 6000), however, as
proposed by Lizana & Hellsing (6) did not enhance the sen-
sitivity for the determination of cerebrospinal fluid proteins.
But it can decrease the antigen-antibody reaction time by a
factor of 10 to 15 (6, 7).
Results
The following detection limits have been found with
0.26 ml native cerebrospinal fluid in the standard assay
(saline omitted) and an incubation time of two hours:
a2-macroglobulin =? 1 mg/1, IgA =1.2 mg/1,
IgM = 0.8 mg/1,0-lipoprotein = 2.6 mg/1.
The normal levels of IgM and j3-lipoprotein could not be
determined in unconeentrated cerebrospinal fluid.
There was a good correlation (tab. 2 and fig. 2) between
the values of albumin, IgG, IgA and a2-macroglobulin in
both serum and cerebrospinal fluid of those 50 patients
that were investigated by both techniques, i. e. the elec-
troimmunoassay and the Laser light scattering immuno^
assay. The concentration range in which both techniques
could be applied and the day-to-day reproducibility
found by Laser-nephelometry are summarized in table 2.
The Laser light scattering immunoassay was performed
on the cerebrospinal fluid (with normal cell count and
normal protein content) from 25 patients between the
3rd and 7th decade of life, who were suffering from a
psychosis — both schizophrenia and cyclothymia — or a
neurosis. This cerebrospinal fluid was taken for differen-
tial diagnostic purposes. The further course of these cases
did not reveal a somatic disorder and conventional labo-
ratory tests were normal. As the concentration of serum-
derived proteins only depends on the actual barrier func-
tion, the serum/cerebrospinal fluid ratios of both albumin
and a2-macroglobulin from these patients served to esta-
blish the lower limit of the normal barrier condition. As
expected from the good correlation (tab. 2 and fig. 2)
between both techniques no substantial difference was
observed between these data and those obtained for the
lower limit of the normal barrier state by the electro-
immunoassay (8). Serum/cerebrospinal fluid ratios
lower than 160 for albumin and lower than 650 for <*2-
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Tab. 2. Coefficient of correlation between the eleetroimmunoassay and the Laser light scattering immunoassay for proteins determined
in serum and cerebrospinal fluid and day-to-day reproducibility found by Laser light scattering immunoassay.
Determined protein Coefficient of
correlation
serum CSF
Concentration range in which
both techniques could be applied
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Fig. 2. Correlation between the Laser light scattering immuno-
assay and the electroimmunoassay demonstrated for the
albumin levels in cerebrospinal fluid. The overall correla-
tion coefficient is r = 0.98 (see tab. 2).
macroglobulin indicate a disturbance of the blood-cere-
brospinal fluid barrier.
The serum/cerebrospinal fluid protein ratios determined
for the remaining 475 patients suffering from a variety
of neurological diseases and psychiatric disorders gene-
rally confirmed those results found with the electro-
immunoassay (3). This was true of both disease groups
i.e. those characterized by "pure" barrier disturbances
and those inflammatory processes showing a local
synthesis of immunogjobulins.
Discussion
The speed with which reliable results are obtained, the
easy handling, and the accuracy and reproducibility of
Laser light scattering immunoassay will favour the appli-
cation of this new technique in many clinical laboratories.
The values obtained correlate well with those obtained
by other tmmunological techniques, e. g. the radial im-
munodiffusion (9) as reported by Sieber & Gross (10),
Pflughaupt (l 1), Pflughaupt et al. (12) and Conrad et al.
(13). We found a good correlation (tab. 2 and fig. 2) be-
tween the results from the electroimmunoassay and those
found by the Laser-nephelometry. The sensitivity of the
electroimmunoassay and the Laser light scattering immu-
noassay is identical for cerebrospinal fluid proteins. The
day-to-day reproducibility (tab. 2) found with the Laser
nephelometry corresponds to results described for the
electroimmunoassay (14). The major disadvantage of
both conventional techniques, i.e. radial immuno-
diffusion and electroimmunoassay, is the time required.
With radial immunodiffusion, results are not available
earlier than 24 hours after starting the assay. For large
proteins even a longer diffusion time has been re-
commended. Although results can be obtained more
rapidly with the electroimmunoassay the carbamylation
procedure necessary for the determination of both IgG
and IgM (15, 16) is time consuming. On the other hand
the Laser light scattering immunoassay is more expen-
sive, because it uses a larger amount of antiserum. If
the amount of antiserum as proposed by the manufactu-
rer is used (5), the consumption of antiserum is four-
fold greater than for the electroimmunoassay. It is,
however, possible to reduce this recommended quantity
of antiserum by 25 or even 50 per cent per test. These
costs are well compensated by the saving of time. Results
from the Laser light scattering immunoassay are received
within 2 and 3 hours after obtaining the sample, whereas
the determination of proteins by the electroimmunoassay
requires nearly 24 hours especially for high-molecular
proteins. Moreover the Behring Laser-Nephelometer can
be connected with a computer to speed up the pro-
cedure. Further mechanisation concerning the pipetting
and dilution of samples is in preparation by the manu-
facturer (5).
The blank value determination was performed according
to Richterich (17). This author has recommended that
the sample blank should be prepared with all reagents,
but with omission of the substance under test. This is a
general recommendation for all biochemical assays
depending on the measurement of light absorption,
fluorescent emission or light scattering. Similar blank
value determinations were performed by Killingworth &
Savory (IS),Ritchie et al. (19) andS/ie/zfrw et al. (20).
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The major advantage of the polyethylene glycol addition
is the acceleration of the antigen-antibody reaction (6, 7).
This acceleration is useful in an automated system, but
unnecessary under manual conditions. A prolongation
of the incubation time up to two hours is useful for bio-
logical fluids poor in proteins.
The question arises as to which proteins should be de-
termined in both serum and cerebrospinal fluid under
routine conditions in a neurological and psychiatric hos-
pital. The evaluation of the blood-cerebrospinal fluid
barrier by serum/cerebrospinal fluid concentration ratios
of both albumin and o^-macroglobulin is a more sensitive
criterion than the determination of the total protein con-
tent (3). Slightly decreased serum/cerebrospinal fluid
ratios of these two proteins may reveal a barrier distur-
bance although the total protein content remains in a
normal range. But the determination of the total protein
content in cerebrospinal fluid is a reliable screening test
to decide which dilution factor is optimal for further
investigations. In this way, unnecessary Laser nephelo-
metric measurements can be prevented.
The applied barrier concept has proved to be a reliable
criterion for deciding whether raised immunoglobulin
levels are the result of passive transfer or of local synthe-
sis within the nervous system. Under normal conditions
the immunoglobulins are subject to the same principle
of transfer from serum into the cerebrospinal fluid com-
partment as are the barrier markers albumin and a2-
macroglobulin. The same is true of "pure" barrier disturb-
ances, whereas a great deviation of the serum/cerebrospinal
fluid immunoglobulin ratios occurs in cases with a local
immunoglobulin synthesis. Delpech & Lichtblau (21)
found a correlation between the cerebrospinal fluid/serum
ratios of both albumin and IgG. In cases with a disturbed
blood-cerebrospinal fluid barrier both ratios increase,
whereas in subjects with an IgG-production a significant
deviation of the cerebrospinal fluid/serum IgG ratios
appears. Their results have been confirmed by Ganrot &
Laurell (22) and Eickhoffet aL (23).
The rational of this coefficient proposed by Delpech &
Lichtblau (21) is the assumption, now well founded, that
the albumin concentration ratio is a valid parameter
under normal and pathological conditions. One can also
choose some other proteins as permeability markers, but
for various practical reasons only albumin, ceruloplasmin
and a2-macroglobulin have been successfully utilized.
Certainly the albumin ratios can be compared with those
of all immunoglobulin classes to detect a local antibody
production, but a complete barrier evaluation should in-
clude a criterion of "selectivity" (24, 25). The linear pro-
tein gradient (serum/cerebrospinal fluid concentration
ratios versus hydrodynamic radii in a semilogarithmic
scale) constructed with albumin and a2-macroglobulin
(26) can be extended into the size range of IgM and |3-
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Fig. 3. Two examples of a disturbed blood-cerebrospinal fluid
barrier:
Moderate barrier disturbance in patient I. N. suffering
from viral meningitis, initial stage and barrier break-
down in patient H. . with pneumococcal meningitis.
The broken line represents the normal protein gradient
between the serum/cerebrospinal fluid ratios of albumin
and a2-macroglobulin; its further extension not yet
established in normal cases is drawn as a dotted line.
In these cases the serum/cerebrospinal fluid ratios of
albumin (©, r = 3.58 nm), IgG (·, r = 5.34 nm), IgA
(H, r = 5.68 nm), IgM (¥, r = 12.1 nm), o^-macroglobulin
(o, r = 9.35 nm) and 0-lipoprotein (a, r = 12.4 nm) con-
centration were determined.
As the concentration ratios of cerebrospinal fluid pro-
teins (a local synthesis of immunoglobulins excluded)
only depends on the actual barrier state, the establish-
ment of normal absolute values is of rather limited signi-
ficance. To avoid misinterpretations, their content in
cerebrospinal fluid can only be evaluated in reference to
their serum counterparts. One female with a normal
barrier condition showed a cerebrospinal fluid IgA level
of 24 mg/1, which was the result of an extremely elevated
serum level due to an IgA myeloma. The serum/cerebro-
spinal fluid IgA ratio in this case had remained in the
normal range.
Under routine conditions the determination of the serum/
cerebrospinal fluid ratios of both albumin and IgG might
be sufficient. But in all inflammatory disorders the addi-
tional measurement of the serum/cerebrospinal fluid
ratios of IgA and IgM is recommended, since an isolated
synthesis of these immunoglobulins may occur.
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